Simplex Trading’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.6K | Sell |
40,600
-40,800
| -50% | -$179K | ﹤0.01% | 5509 |
|
|
2025
Q4 | $422K | Buy |
81,400
+57,400
| +239% | +$295K | ﹤0.01% | 3475 |
|
|
2025
Q3 | $125K | Sell |
24,000
-64,900
| -73% | -$338K | ﹤0.01% | 5490 |
|
|
2025
Q2 | $340K | Buy |
88,900
+39,100
| +79% | +$101K | ﹤0.01% | 3918 |
|
|
2025
Q1 | $286K | Sell |
49,800
-105,900
| -68% | -$626K | ﹤0.01% | 3958 |
|
|
2024
Q4 | $776K | Buy |
155,700
+23,100
| +17% | +$119K | ﹤0.01% | 3102 |
|
|
2024
Q3 | $714K | Buy |
132,600
+30,600
| +30% | +$146K | ﹤0.01% | 3234 |
|
|
2024
Q2 | $337K | Sell |
102,000
-5,200
| -5% | -$20.4K | ﹤0.01% | 4092 |
|
|
2024
Q1 | $350K | Buy |
107,200
+104,300
| +3,597% | +$343K | ﹤0.01% | 4221 |
|
|
2023
Q4 | $10K | Sell |
2,900
-43,800
| -94% | -$135K | ﹤0.01% | 7400 |
|
|
2023
Q3 | $311K | Buy |
46,700
+9,100
| +24% | +$67.5K | ﹤0.01% | 3902 |
|
|
2023
Q2 | $315K | Buy |
37,600
+17,200
| +84% | +$169K | ﹤0.01% | 3776 |
|
|
2023
Q1 | $202K | Sell |
20,400
-43,900
| -68% | -$310K | ﹤0.01% | 4305 |
|
|
2022
Q4 | $447K | Buy |
64,300
+54,000
| +524% | +$309K | ﹤0.01% | 3271 |
|
|
2022
Q3 | $55K | Sell |
10,300
-86,600
| -89% | -$520K | ﹤0.01% | 6303 |
|
|
2022
Q2 | $386K | Sell |
96,900
-87,500
| -47% | -$301K | ﹤0.01% | 3774 |
|
|
2022
Q1 | $819K | Sell |
184,400
-30,800
| -14% | -$123K | ﹤0.01% | 3154 |
|
|
2021
Q4 | $860K | Buy |
215,200
+168,900
| +365% | +$1.29M | ﹤0.01% | 3074 |
|
|
2021
Q3 | $523K | Sell |
46,300
-1,500
| -3% | -$13.8K | ﹤0.01% | 4040 |
|
|
2021
Q2 | $541K | Buy |
47,800
+47,793
| +682,757% | +$575K | ﹤0.01% | 4034 |
|
|
2021
Q1 | $8K | Sell |
7
-32
| -82% | -$368 | ﹤0.01% | 7998 |
|
|
2020
Q4 | $26K | Buy |
39
+5
| +15% | +$35 | ﹤0.01% | 6773 |
|
|
2020
Q3 | $25K | Buy |
34
+16
| +89% | +$103 | ﹤0.01% | 6201 |
|
|
2020
Q2 | $7K | Buy |
+18
| New | +$66 | ﹤0.01% | 6802 |
|
|
2020
Q1 | – | Sell |
-13
| Closed | -$7K | – | 7513 |
|
|
2019
Q4 | $7K | Sell |
13
-20
| -61% | -$116 | ﹤0.01% | 6534 |
|
|
2019
Q3 | $17K | Sell |
33
-370
| -92% | -$1.99K | ﹤0.01% | 5913 |
|
|
2019
Q2 | $241K | Sell |
403
-291
| -42% | -$2.19K | ﹤0.01% | 3280 |
|
|
2019
Q1 | $626K | Buy |
694
+690
| +17,250% | +$5.86K | ﹤0.01% | 2424 |
|
|
2018
Q4 | $3K | Sell |
4
-1
| -20% | -$10 | ﹤0.01% | 6386 |
|
|
2018
Q3 | $6K | Buy |
+5
| New | +$41 | ﹤0.01% | 6659 |
|
Other funds holding ALDX
KCM
VCM
KCM
6CM
Simplex Trading's ALDX Position: Q1 2026 in Review
Simplex Trading sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 39,755 shares — an estimated $174K sold.
Simplex Trading first reported a position in ALDX in Q1 2018 and held it in 25 quarters. The position peaked at $810K in Q3 2018. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.
- Simplex Trading reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 39,755 Aldeyra Therapeutics shares in Q1 2026, an estimated $174K.
- Simplex Trading first reported a position in Aldeyra Therapeutics in Q1 2018 and held it in 25 quarters.
- Simplex Trading's Aldeyra Therapeutics position peaked at $810K in Q3 2018.
- 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.